Home › NDC Lookup › RxCUI directory › RxCUI 311359

Ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet — RxCUI 311359

Name: Ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet (RxCUI 311359)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 311359 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311359

Official nameEthinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asethinyl estradiol 30 MCG / norgestrel 0.3 MG Oral Tablet

FDA products mapped9

Package NDCs mapped12

Reported Medicaid activity (SDUD)132,792 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet RxCUI 311359 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 3

The active substance itself — no strength, form, or brand attached yet.
- Ethinyl estradiol 4124 IN
- Norgestrel 7518 IN
- Ethinyl estradiol / norgestrel 37075 MIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ethinyl estradiol / norgestrel Oral Tablet 373122 SCDF
- Ethinyl estradiol / norgestrel Oral Product 1157356 SCDG
- Ethinyl estradiol / norgestrel Pill 1157357 SCDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- Pill 1151133 DFG
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Ethinyl estradiol 0.03 MG 315897 SCDC
- Norgestrel 0.3 MG 317447 SCDC
Packs 5

Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

{21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack GPCK · 749786
Ethinyl estradiol 0.03 MG SCDC · 315897
Norgestrel 0.3 MG SCDC · 317447
Ethinyl estradiol / norgestrel Oral Tablet SCDF · 373122
Ethinyl estradiol / norgestrel Oral Product SCDG · 1157356
Ethinyl estradiol / norgestrel Pill SCDG · 1157357

Brand-Name Concepts

📦 FDA Products & Package NDCs

9 products · 12 package NDCs

12 package NDCs map to RxCUI 311359 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00480-3493-16	6 POUCH in 1 CARTON (0480-3493-16) / 1 BLISTER PACK in 1 PO...	Cryselle	Teva Pharmaceuticals, Inc.	2025-12-12
00555-9049-58	6 POUCH in 1 CARTON (0555-9049-58) / 1 BLISTER PACK in 1 PO...	Cryselle	Teva Pharmaceuticals USA, Inc.	2002-07-24
16714-0365-01	1 BLISTER PACK in 1 PACKET (16714-365-01) / 1 KIT in 1 BLIS...	Elinest	Northstar Rx LLC	2012-01-07
16714-0365-02	1 BLISTER PACK in 1 CARTON (16714-365-02) / 1 KIT in 1 BLIS...	Elinest	Northstar Rx LLC	2012-01-07
16714-0365-03	3 BLISTER PACK in 1 CARTON (16714-365-03) / 1 KIT in 1 BLIS...	Elinest	Northstar Rx LLC	2012-01-07
16714-0365-04	6 BLISTER PACK in 1 CARTON (16714-365-04) / 1 KIT in 1 BLIS...	Elinest	Northstar Rx LLC	2012-01-07
50090-2183-00	1 KIT in 1 KIT (50090-2183-0)	Cryselle	A-S Medication Solutions	2015-10-26
50090-7917-00	6 POUCH in 1 CARTON (50090-7917-0) / 1 BLISTER PACK in 1 PO...	Cryselle	A-S Medication Solutions	2026-02-25
50090-7978-00	1 KIT in 1 KIT (50090-7978-0)	Turqoz	A-S Medication Solutions	2026-05-20
51862-0564-06	6 BLISTER PACK in 1 CARTON (51862-564-06) / 1 KIT in 1 BLIS...	Low-Ogestrel	Mayne Pharma Inc.	2016-08-03
68180-0895-13	3 BLISTER PACK in 1 CARTON (68180-895-13) / 1 KIT in 1 BLIS...	Turqoz	Lupin Pharmaceuticals, Inc.	2023-11-29
71205-0803-28	1 KIT in 1 POUCH (71205-803-28)	Cryselle	Proficient Rx LP	2023-05-30

Observed labelers: Northstar Rx LLC (4) · A-S Medication Solutions (3) · Lupin Pharmaceuticals, Inc. (1) · Mayne Pharma Inc. (1) · Proficient Rx LP (1) · Teva Pharmaceuticals USA, Inc. (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.